Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05196_nanopub.RAvY0gh5P-rR-yUsj5J0y-SwAc2YHp5YJGcSXB8kDLt_Q#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05196 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05196 label "ACR325 [drugbank:DB05196]" assertion.
- drugbank:DB05196 seeAlso DB05196 assertion.
- drugbank:DB05196 description "ACR325 is developed for the treatment of Parkinsonâs disease and psychoses, including bipolar disorder, for which disease existing therapies have only limited effect and considerable adverse side effects. ACR325 is a dopaminergic stabiliser, which has demonstrated promising results in disease models for motor functions and psychoses." assertion.
- drugbank:DB05196 identifier "drugbank:DB05196" assertion.
- drugbank:DB05196 title "ACR325" assertion.
- drugbank:DB05196 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05196 drugbank_vocabulary:drugbank-id "DB05196" assertion.
- drugbank:DB05196 bio2rdf_vocabulary:x-identifiers.org DB05196 assertion.
- drugbank:DB05196 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05196" assertion.
- drugbank:DB05196 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05196 bio2rdf_vocabulary:identifier "DB05196" assertion.